Silberstein Charles Insider Trades

Insider Trading History

Track insider trading activity for Silberstein Charles. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Applied Therapeutics
Applied Therapeutics APLT
Chief Financial Officer
Holding Value $18.9k 183,603 shares
Last Trade
Jan 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$133k 32,000 shares
$4.17
$0.10
Applied Therapeutics
Applied Therapeutics APLT
Chief Financial Officer
Holding Value $14k 135,703 shares
Last Trade
Dec 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$452k 47,900 shares
$9.44
$0.10
Applied Therapeutics
Applied Therapeutics APLT
Chief Financial Officer
Holding Value $14k 135,703 shares
Last Trade
Dec 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$302k 32,000 shares
$9.44
$0.10
Applied Therapeutics
Applied Therapeutics APLT
Chief Financial Officer
Holding Value $9.04k 87,803 shares
Last Trade
Jun 08, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$108k 5,047 shares
$21.42
$0.10
Applied Therapeutics
Applied Therapeutics APLT
Chief Financial Officer
Holding Value $9.56k 92,850 shares
Last Trade
Dec 10, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.15M 92,850 shares
$23.15
$0.10
Applied Therapeutics
Applied Therapeutics APLT
Chief Financial Officer
Holding Value $18.8k 183,000 shares
Last Trade
Jun 04, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.7M 244,000 shares
$44.02
$0.10

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up